SourceOne Stock Info  Your one source site for stock research

 

 

 

Company Website

Investor Relations

 

 

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

 

 

 

 

 

 

 

 

Biogen Idec Inc

 

BIIB

Biogen Idec Inc. is engaged in the research, development, manufacturing and commercialization of therapies. Biogen Idec has five products: AVONEX, RITUXAN and ZEVALIN, TYSABRI and AMEVIVE. AVONEX is for the treatment of relapsing forms of multiple sclerosis. RITUXAN and ZEVALIN are for the treatment of certain B-cell non-Hodgkin's lymphomas. TYSABRI, formerly known as ANTEGREN, is approved by the United States Food and Drug Administration (FDA) to treat relapsing forms of MS to reduce the frequency of clinical relapses. AMEVIVE is approved in the United States for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

 

Stock Quotes and Other Information

Nasdaq

NYSE

Msn

Yahoo

Silicon Investor

Excite

Lycos

Market Watch

Clear Station

StockHouse

 

SourceOne Message Board

 

Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35

 

Home